Skip to main content
. 2017 Sep 12;8(49):85984–85996. doi: 10.18632/oncotarget.20841

Figure 2. miR-296-5p inhibits long-term viability, migration and invasion of breast cancer cells.

Figure 2

(A) Clonogenic assay on mock, miR-296-5p or miR-296-5p inhibitor (anti-miR-296-5p)-transfected MDA-MB-231 cells. Bar graph shows number of colonies counted microscopically in ten different fields. (B, C) Photomicrographs showing migrated (B) and invaded (C) MDA-MB-231 cells transfected with mock, miR-296-5p or miR-296-5p inhibitor (anti-miR-296-5p). Bar graphs show number of migrated and invaded cells. The data shown are mean ± SD for at least three independent experiments. ***, p<0.001; **, p<0.01 versus control group, ANOVA.